Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.90
-$0.08 (-1.00%)
Pre-market:
Sep 22, 2026, 5:48 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 84.54M | 143.86M | 167.2M | 111.07M | 203.57M | 312.42M | 561.57M | 616.21M | 730.37M | 843.77M | 944.07M | 1.05B | 1.11B | 1.21B | 1.32B | 1.3B | 1.38B | 1.49B | 1.55B | 1.74B | 235.89M | 308.13M |
Short-Term Investments | 217.63M | 229.59M | 255.42M | 350.8M | 270.13M | 204.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 22.39M | 14.7M | 15.07M | 30.18M | 32.45M | 31.96M | 48.47M | 61.85M | 62.49M | 133.94M | 77.91M | 85.61M | 121.06M | 122.94M | 113.73M | 100.45M | 95.98M | 111.24M | 115.23M | 121.13M | 110.13M | 111.72M |
Other Long-Term Assets | 85.89M | 42.73M | 47.17M | 46.59M | 47.24M | 46.99M | 55.57M | 60.04M | 60.21M | 2.71M | 58.71M | 97.02M | 97.95M | 97.26M | 88.73M | 43.93M | 53.02M | 49.62M | 43.99M | 36.96M | 42.09M | 22.65M |
Receivables | 13.01M | 19.82M | 24.03M | 21.43M | 23.13M | 27.17M | 22.44M | 23.94M | 18.89M | 24.56M | 17.9M | 63.14M | 68.92M | 84.84M | 82.47M | 115.76M | 174.88M | 171.07M | 149.9M | 50.73M | 28.39M | 31.45M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46K | 70K | 391K | 2.51M | 4.36M | 5.86M | 8.1M | 8.7M | 3.36M | 3.47M | 2.72M | 3.42M |
Other Current Assets | n/a | 16.68M | 25.19M | 22.79M | 26.21M | 20.44M | 18.73M | 22.32M | 13.29M | 12.8M | 18.99M | 29.39M | 27.04M | 8.51M | 12.35M | 18.42M | 22.01M | 14.34M | 698K | 3.91M | 3.1M | 2.01M |
Total Current Assets | 332.54M | 409.96M | 471.84M | 506.08M | 523.03M | 564.53M | 602.74M | 662.48M | 783.36M | 903.02M | 1B | 1.14B | 1.22B | 1.33B | 1.45B | 1.46B | 1.6B | 1.71B | 1.72B | 1.81B | 284.07M | 362.2M |
Property-Plant & Equipment | 504.85M | 516.82M | 528.7M | 544.79M | 562.15M | 581.22M | 598.16M | 616.95M | 628.59M | 416.78M | 394.99M | 543.21M | 685.67M | 702.24M | 715.54M | 187.58M | 176.22M | 149.17M | 145.77M | 142.7M | 145.88M | 141.92M |
Goodwill & Intangibles | 44.39M | 48.86M | 56.92M | 61.52M | 66.15M | 68.76M | 72.51M | 79.57M | 90.6M | 125.32M | 131.98M | 158.23M | 163.86M | 167.46M | 171.25M | 76.74M | 70.15M | 41.87M | 42.95M | 39.23M | 4.88M | 5.01M |
Total Long-Term Assets | 657.51M | 623.12M | 647.86M | 683.08M | 707.98M | 728.93M | 774.71M | 818.4M | 841.89M | 678.74M | 663.59M | 884.55M | 1.07B | 1.09B | 1.09B | 408.69M | 395.37M | 351.89M | 347.95M | 340.02M | 302.98M | 281.3M |
Total Assets | 990.05M | 1.03B | 1.12B | 1.19B | 1.23B | 1.29B | 1.38B | 1.48B | 1.63B | 1.58B | 1.67B | 2.03B | 2.29B | 2.42B | 2.54B | 1.87B | 1.99B | 2.06B | 2.07B | 2.15B | 587.05M | 643.5M |
Account Payables | 9.58M | 16.31M | 10.57M | 10.7M | 11.2M | 11.27M | 14.17M | 15.7M | 23.03M | 27M | 9.32M | 10.75M | 13.63M | 21.57M | 10.45M | 11.32M | 19.46M | 35.26M | 8.19M | 7.1M | 2.77M | 14.23M |
Deferred Revenue | 13.21M | 14.91M | 19.98M | 25.24M | 28.29M | 33.65M | 30.6M | 22.89M | 26.01M | 33.61M | 48.5M | 42.76M | n/a | 47.52M | 47.82M | 40.51M | 45.5M | 35.23M | 33.24M | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 48.38M | 32.12M | 79.34M | n/a | n/a | 26.62M | n/a | n/a | n/a | 54.38M | n/a | 39.22M | n/a | 65.92M | n/a | n/a | n/a | 40.31M | 29.65M | 31.3M | 33.25M |
Total Current Liabilities | 72.74M | 79.6M | 95.97M | 115.28M | 96.72M | 115.67M | 107.27M | 114.43M | 166.15M | 169.04M | 163.86M | 168.46M | 163.33M | 191.7M | 172.96M | 124.82M | 135.02M | 159.25M | 134.76M | 90.31M | 81.09M | 99.01M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 16.37M | 21.73M | 22.88M | 17.16M | 17.94M | 15.43M | 16.58M | 17.67M | 20.9M | 24.88M | 24.43M | 31.57M | 214.15M | 39.01M | 42.06M | 95.66M | 83.62M | 86.95M | 190.58M | 422.27M | 133.81M | 132.48M |
Total Long-Term Liabilities | 497.02M | 510.33M | 515.14M | 514.1M | 521.34M | 530.37M | 554.13M | 568.51M | 626.03M | 425.45M | 404.33M | 605.25M | 625.08M | 617.92M | 630.08M | 306.14M | 292.14M | 284.43M | 368.85M | 442.32M | 150.17M | 148.92M |
Total Liabilities | 569.76M | 589.92M | 611.11M | 629.38M | 618.06M | 646.04M | 661.39M | 682.94M | 792.18M | 594.49M | 568.19M | 773.71M | 788.41M | 809.62M | 803.04M | 430.96M | 427.16M | 443.68M | 503.61M | 532.62M | 231.26M | 247.93M |
Total Debt | 404.11M | 410.7M | 439.89M | 422.87M | 428.83M | 434.56M | 467.73M | 445.59M | 452.27M | 234.5M | 239.31M | 403.66M | 410.94M | 404.1M | 442.59M | 59.84M | 51.55M | 27.31M | 23.03M | 16.27M | 16.36M | 16.44M |
Book Value | 420.28M | 443.15M | 508.59M | 559.78M | 612.95M | 647.43M | 716.06M | 797.94M | 833.07M | 987.27M | 1.1B | 1.25B | 1.5B | 1.61B | 1.74B | 1.44B | 1.57B | 1.61B | 1.57B | 1.62B | 355.79M | 395.57M |
Book Value Per Share | 6.77 | 7.44 | 9.17 | 10.06 | 11.17 | 11.94 | 13.80 | 15.27 | 16.22 | 19.75 | 22.18 | 25.69 | 31.11 | 33.55 | 37.41 | 35.31 | 38.68 | 40.16 | 40.94 | 48.90 | 11.01 | 12.26 |
Common Stock | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 206K | 202K | 5K | 198K | 196K | 194K | 190K | 165K | 164K | 162K | 161K | 148K | 79K | 79K |
Retained Earnings | -6.28B | -6.23B | -6.15B | -6.07B | -5.99B | -5.93B | -5.84B | -5.73B | -5.67B | -5.46B | -5.29B | -5.08B | -4.78B | -4.6B | -4.4B | -4.23B | -3.56B | -2.89B | -2.3B | -697.27M | -595.39M | -541.45M |
Comprehensive Income | 950K | 1.19M | 1.85M | 2M | 1.65M | -850K | -1.81M | 263K | -1.72M | -1.55M | 1.48M | -2.9M | -1.3M | -1.61M | -2.63M | -7.91M | -5.5M | -2.36M | -1.72M | -877K | 0 | 0 |
Shareholders Equity | 420.28M | 443.15M | 508.59M | 559.78M | 612.95M | 647.43M | 716.06M | 797.94M | 833.07M | 987.27M | 1.1B | 1.25B | 1.5B | 1.61B | 1.74B | 1.43B | 1.54B | 1.58B | 1.51B | 1.55B | 348.84M | 388.1M |
Total Investments | 240.02M | 244.3M | 270.48M | 380.97M | 302.57M | 236.46M | 48.47M | 61.85M | 62.49M | 133.94M | 77.91M | 85.61M | 121.06M | 122.94M | 113.73M | 100.45M | 95.98M | 111.24M | 115.23M | 121.13M | 110.13M | 111.72M |
Add to Watchlist
Select watchlists to add or remove DNA